Published in J Oncol Pract on May 01, 2011
Patterns of care among patients receiving radiation therapy for bone metastases at a large academic institution. Int J Radiat Oncol Biol Phys (2014) 2.18
Provider-based research networks and diffusion of surgical technologies among patients with early-stage kidney cancer. Cancer (2014) 1.40
Deviations from guideline-based therapy for febrile neutropenia in cancer patients and their effect on outcomes. JAMA Intern Med (2013) 1.13
Cancer Care Delivery Research: Building the Evidence Base to Support Practice Change in Community Oncology. J Clin Oncol (2015) 1.03
Quality measures for palliative care in patients with cancer: a systematic review. J Oncol Pract (2014) 0.94
The Victorian Lung Cancer Registry pilot: improving the quality of lung cancer care through the use of a disease quality registry. Lung (2014) 0.91
Use of care management practices in small- and medium-sized physician groups: do public reporting of physician quality and financial incentives matter? Health Serv Res (2012) 0.89
Perspectives of quality care in cancer treatment: a review of the literature. Am Health Drug Benefits (2013) 0.88
Feasibility of using algorithm-based clinical decision support for symptom assessment and management in lung cancer. J Pain Symptom Manage (2014) 0.85
Physician inter-annotator agreement in the Quality Oncology Practice Initiative manual abstraction task. J Oncol Pract (2013) 0.83
Clinical practice guidelines for cancer care: utilization and expectations of the practicing oncologist. J Oncol Pract (2012) 0.78
Evaluating the effect of clinical care pathways on quality of cancer care: analysis of breast, colon and rectal cancer pathways. J Cancer Res Clin Oncol (2016) 0.77
Evolution of the Quality Oncology Practice Initiative supportive care quality measures portfolio and conformance at a Veterans Affairs medical center. J Oncol Pract (2013) 0.75
Physician level reporting of surgical and pathology performance indicators: a regional study to assess feasibility and impact on quality. Can J Surg (2015) 0.75
Applying Metrics to Outpatient Oncology Advanced Practice Providers. J Adv Pract Oncol (2016) 0.75
Screening for symptom burden and supportive needs of patients with glioblastoma and brain metastases and their caregivers in relation to their use of specialized palliative care. Support Care Cancer (2017) 0.75
Impact of Palliative Medicine Involvement on End-of-Life Services for Patients With Cancer With In-Hospital Deaths. J Oncol Pract (2017) 0.75
The American Society of Breast Surgeons and Quality Payment Programs: Ranking, Defining, and Benchmarking More Than 1 Million Patient Quality Measure Encounters. Ann Surg Oncol (2017) 0.75
Early palliative care for patients with metastatic non-small-cell lung cancer. N Engl J Med (2010) 29.06
The triple aim: care, health, and cost. Health Aff (Millwood) (2008) 24.55
Associations between end-of-life discussions, patient mental health, medical care near death, and caregiver bereavement adjustment. JAMA (2008) 11.32
Health care costs in the last week of life: associations with end-of-life conversations. Arch Intern Med (2009) 6.46
Survival of Medicare patients after enrollment in hospice programs. N Engl J Med (1996) 6.14
Aggressiveness of cancer care near the end of life: is it a quality-of-care issue? J Clin Oncol (2008) 5.61
A process for measuring the quality of cancer care: the Quality Oncology Practice Initiative. J Clin Oncol (2005) 5.23
Medicare program expenditures associated with hospice use. Ann Intern Med (2004) 2.66
Resource utilization for ovarian cancer patients at the end of life: how much is too much? Gynecol Oncol (2005) 2.26
Why observational studies should be among the tools used in comparative effectiveness research. Health Aff (Millwood) (2010) 2.11
Use of chemotherapy at end of life in oncology patients. Ann Oncol (2009) 1.41
Development of stroke performance measures: definitions, methods, and current measures. Stroke (2010) 1.34
Indicators of survival duration in ovarian cancer and implications for aggressiveness of care. Cancer (2008) 1.13
End-of-life care in patients with lung cancer. Chest (2003) 1.06
Gynecologic oncology patients' satisfaction and symptom severity during palliative chemotherapy. Health Qual Life Outcomes (2006) 1.00
Complications at the end of life in ovarian cancer. J Pain Symptom Manage (2007) 0.92
A framework for assessing quality indicators for cancer care at the end of life. J Pain Symptom Manage (2009) 0.89
Partnering with payers for success: quality oncology practice initiative, blue cross blue shield of michigan, and the michigan oncology quality consortium. J Oncol Pract (2009) 0.86
Medicare head Donald M. Berwick, MD, takes on mission of health system reform. Interview by Mike Mitka. JAMA (2010) 0.81
Health care costs in the last week of life: associations with end-of-life conversations. Arch Intern Med (2009) 6.46
Comparisons of patient and physician expectations for cancer survivorship care. J Clin Oncol (2009) 4.39
Does reimbursement influence chemotherapy treatment for cancer patients? Health Aff (Millwood) (2006) 4.33
Family caregiver burden: results of a longitudinal study of breast cancer patients and their principal caregivers. CMAJ (2004) 4.13
Frequency and cost of chemotherapy-related serious adverse effects in a population sample of women with breast cancer. J Natl Cancer Inst (2006) 4.01
Physician factors associated with discussions about end-of-life care. Cancer (2010) 3.54
Prospective study of bevacizumab plus temozolomide in patients with advanced neuroendocrine tumors. J Clin Oncol (2012) 3.36
How Medicare's payment cuts for cancer chemotherapy drugs changed patterns of treatment. Health Aff (Millwood) (2010) 3.24
Prognostic factors following curative resection for pancreatic adenocarcinoma: a population-based, linked database analysis of 396 patients. Ann Surg (2003) 3.13
Preventive care for colorectal cancer survivors: a 5-year longitudinal study. J Clin Oncol (2008) 2.68
Trends in follow-up and preventive care for colorectal cancer survivors. J Gen Intern Med (2008) 2.64
Association of hospital spending intensity with mortality and readmission rates in Ontario hospitals. JAMA (2012) 2.47
Improvement in oncology practice performance through voluntary participation in the Quality Oncology Practice Initiative. J Clin Oncol (2008) 2.39
Comparing care for breast cancer survivors to non-cancer controls: a five-year longitudinal study. J Gen Intern Med (2009) 2.36
Measuring disease-free survival and cancer relapse using Medicare claims from CALGB breast cancer trial participants (companion to 9344). J Natl Cancer Inst (2006) 2.34
Quality of care for older patients with cancer in the Veterans Health Administration versus the private sector: a cohort study. Ann Intern Med (2011) 2.34
Trends in the aggressiveness of end-of-life cancer care in the universal health care system of Ontario, Canada. J Clin Oncol (2011) 2.31
Follow-up of patients with curatively resected colorectal cancer: a practice guideline. BMC Cancer (2003) 2.26
Prevention, screening, and surveillance care for breast cancer survivors compared with controls: changes from 1998 to 2002. J Clin Oncol (2009) 2.26
The interface between primary and oncology specialty care: treatment through survivorship. J Natl Cancer Inst Monogr (2010) 2.25
Revisions to the 2009 american society of clinical oncology/oncology nursing society chemotherapy administration safety standards: expanding the scope to include inpatient settings. J Oncol Pract (2011) 2.21
The effect of race on invasive staging and surgery in non-small-cell lung cancer. J Clin Oncol (2005) 2.21
End-of-life care discussions among patients with advanced cancer: a cohort study. Ann Intern Med (2012) 2.08
Measuring complications of cancer treatment using the SEER-Medicare data. Med Care (2002) 2.05
End-of-life care for older cancer patients in the Veterans Health Administration versus the private sector. Cancer (2010) 2.01
Physician roles in the cancer-related follow-up care of cancer survivors. Fam Med (2013) 2.00
Survival of older patients with cancer in the Veterans Health Administration versus fee-for-service Medicare. J Clin Oncol (2012) 2.00
Associations between end-of-life discussion characteristics and care received near death: a prospective cohort study. J Clin Oncol (2012) 1.95
The outcomes and costs of acute myeloid leukemia among the elderly. Arch Intern Med (2002) 1.90
Discussions with physicians about hospice among patients with metastatic lung cancer. Arch Intern Med (2009) 1.77
Looking back from death: the value of retrospective studies of end-of-life care. J Clin Oncol (2006) 1.75
Racial and ethnic differences in end-of-life care in fee-for-service Medicare beneficiaries with advanced cancer. J Am Geriatr Soc (2008) 1.74
Breast cancer survivors' perceptions of survivorship care options. J Clin Oncol (2011) 1.72
Comparison of prospective and retrospective indicators of the quality of end-of-life cancer care. J Clin Oncol (2008) 1.70
Measuring supportive care in medical oncology practice: lessons learned from the quality oncology practice initiative. J Clin Oncol (2008) 1.67
The effect on survival of continuing chemotherapy to near death. BMC Palliat Care (2011) 1.66
Phase II study of capecitabine, oxaliplatin, and erlotinib in previously treated patients with metastastic colorectal cancer. J Clin Oncol (2006) 1.64
Health care costs associated with hepatocellular carcinoma: a population-based study. Hepatology (2013) 1.63
Hospital characteristics, clinical severity, and outcomes for surgical oncology patients. Surgery (2010) 1.62
Towards using administrative databases to measure population-based indicators of quality of end-of-life care: testing the methodology. Palliat Med (2006) 1.60
Ten-year survival and cost following breast cancer recurrence: estimates from SEER-medicare data. Value Health (2008) 1.48
Lower use of hospice by cancer patients who live in minority versus white areas. J Gen Intern Med (2007) 1.47
Behavioral health services for women who have breast cancer. J Clin Oncol (2008) 1.45
Racial differences in surgical evaluation, treatment, and outcome of locoregional esophageal cancer: a population-based analysis of elderly patients. J Clin Oncol (2005) 1.44
Treatment of locally advanced pancreatic cancer in the real world: population-based practices and effectiveness. J Clin Oncol (2003) 1.41
Factors associated with improved survival among older colorectal cancer patients in the US: a population-based analysis. BMC Cancer (2009) 1.40
Surgical mortality in patients with esophageal cancer: development and validation of a simple risk score. J Clin Oncol (2006) 1.39
Preventive care in prostate cancer patients: following diagnosis and for five-year survivors. J Cancer Surviv (2011) 1.38
Racial segregation and disparities in cancer stage for seniors. J Gen Intern Med (2008) 1.36
Etiology of delays in the initiation of adjuvant chemotherapy and their impact on outcomes for Stage II and III rectal cancer. Dis Colon Rectum (2009) 1.33
Lifetime and treatment-phase costs associated with colorectal cancer: evidence from SEER-Medicare data. Clin Gastroenterol Hepatol (2008) 1.33
Quality of care for comorbid conditions during the transition to survivorship: differences between cancer survivors and noncancer controls. J Clin Oncol (2013) 1.32
Measuring the improving quality of outpatient care in medical oncology practices in the United States. J Clin Oncol (2013) 1.30
How does initial treatment choice affect short-term and long-term costs for clinically localized prostate cancer? Cancer (2010) 1.30
Referral patterns, treatment choices, and outcomes in locoregional esophageal cancer: a population-based analysis of elderly patients. J Clin Oncol (2007) 1.29
Racial segregation and disparities in breast cancer care and mortality. Cancer (2008) 1.28
Effect of distance to radiation treatment facility on use of radiation therapy after mastectomy in elderly women. Int J Radiat Oncol Biol Phys (2006) 1.25
Associations among cancer survivorship discussions, patient and physician expectations, and receipt of follow-up care. J Clin Oncol (2010) 1.23
The economic cost of squamous cell cancer of the head and neck: findings from linked SEER-Medicare data. Arch Otolaryngol Head Neck Surg (2004) 1.22
Hospice care and survival among elderly patients with lung cancer. J Palliat Med (2011) 1.22
Lung cancer treatment costs, including patient responsibility, by disease stage and treatment modality, 1992 to 2003. Value Health (2011) 1.22
Methodological issues in the use of administrative claims data to study surveillance after cancer treatment. Med Care (2002) 1.21
Racial composition of hospitals: effects on surgery for early-stage non-small-cell lung cancer. J Clin Oncol (2008) 1.21
Disparities in hospice care among older women dying with ovarian cancer. Gynecol Oncol (2011) 1.20
Physician preferences and attitudes regarding different models of cancer survivorship care: a comparison of primary care providers and oncologists. J Cancer Surviv (2013) 1.18
Geographic variation in physicians' responses to a reimbursement change. N Engl J Med (2011) 1.18
Implementing a breast cancer registry and treatment plan/summary program in clinical practice: a pilot program. Cancer (2012) 1.17
American Society of Clinical Oncology National Census of Oncology Practices: preliminary report. J Oncol Pract (2013) 1.16
Phase-II study of gemcitabine and cisplatin in patients with metastatic biliary and gallbladder cancer. Dig Dis Sci (2007) 1.15
Variation in use of surveillance colonoscopy among colorectal cancer survivors in the United States. BMC Health Serv Res (2010) 1.15
Toward population-based indicators of quality end-of-life care: testing stakeholder agreement. Cancer (2008) 1.14
Trends in the treatment of acute myeloid leukaemia in the elderly. Drugs Aging (2005) 1.14
Diagnostic delay and complications for older adults with multiple myeloma. Leuk Lymphoma (2009) 1.14
Progress for resectable pancreatic [corrected] cancer?: a population-based assessment of US practices. Cancer (2010) 1.13
Patient and treatment factors associated with complications after prostate brachytherapy. J Clin Oncol (2006) 1.13
Cancer survivorship research and guidelines: maybe the cart should be beside the horse. J Clin Oncol (2007) 1.11
Use of palliative radiotherapy among patients with metastatic non-small-cell lung cancer. Int J Radiat Oncol Biol Phys (2007) 1.10
Racial differences in cancer specialist consultation, treatment, and outcomes for locoregional pancreatic adenocarcinoma. Ann Surg Oncol (2009) 1.10
A phase II trial of irinotecan and cisplatin in patients with metastatic neuroendocrine tumors. Dig Dis Sci (2006) 1.09
Patterns of care for radical prostatectomy in the United States from 2003 to 2005. J Urol (2008) 1.08
A phase II trial of gemcitabine in patients with advanced hepatocellular carcinoma. Cancer (2002) 1.06
Regional variation in cancer-directed surgery and mortality among women with epithelial ovarian cancer in the Medicare population. Cancer (2010) 1.05
Impact of patient age and comorbidity on surgeon versus oncologist preferences for adjuvant chemotherapy for stage III colon cancer. J Am Coll Surg (2008) 1.00
A Phase II study of gemcitabine and docetaxel in patients with metastatic pancreatic carcinoma. Cancer (2002) 0.98
Breast biopsy patterns and outcomes in Surveillance, Epidemiology, and End Results-Medicare data. Cancer (2009) 0.95
Timeliness and quality of diagnostic care for medicare recipients with chronic lymphocytic leukemia. Cancer (2010) 0.95
A retrospective analysis of disability and its related costs among employees with chronic obstructive pulmonary disease. J Occup Environ Med (2007) 0.95
Neoadjuvant or adjuvant therapy for resectable gastric cancer: a systematic review and practice guideline for North America. Gastric Cancer (2012) 0.95
Adjuvant therapy for elderly patients with resected gastric adenocarcinoma: population-based practices and treatment effectiveness. Cancer (2011) 0.94
Provider case volume and outcomes following prostate brachytherapy. J Urol (2008) 0.94
Delays in referral and diagnosis for chronic hematologic malignancies: a literature review. Leuk Lymphoma (2008) 0.94
Completion of adjuvant chemotherapy and use of health services for older women with epithelial ovarian cancer. J Clin Oncol (2011) 0.90
Patterns of care studies: creating "an environment of watchful concern". J Clin Oncol (2003) 0.90
Hepatobiliary cancers. Clinical practice guidelines in oncology. J Natl Compr Canc Netw (2006) 0.90
Journal of Clinical Oncology update on progress in cancer survivorship care and research. J Clin Oncol (2012) 0.88
Does Type of Tumor Histology Impact Survival among Patients with Stage IIIB/IV Non-Small Cell Lung Cancer Treated with First-Line Doublet Chemotherapy? Chemother Res Pract (2010) 0.86
Using economic analysis to evaluate the potential of multimodality therapy for elderly patients with locally advanced pancreatic cancer. Int J Radiat Oncol Biol Phys (2007) 0.86
The combination of capecitabine and thalidomide in previously treated, refractory metastatic colorectal cancer. Am J Clin Oncol (2006) 0.86